Former Georgia insurance commissioner sentenced to prison for $3M fraud scheme

The former insurance commissioner of Georgia is heading to prison for an unnecessary lab testing scheme that involved $3 million worth of insurance claims.

John Oxendine has been sentenced to three and a half years after being convicted of conspiracy to commit healthcare fraud. The U.S. Department of Justice (DOJ) said he conspired with a physician, Jeffrey Gallups, MD, to submit fraudulent claims for unnecessary lab tests. The duo netted $260,000 in kickbacks. 

Physicians in Gallups’ practice were pressured to order tests from Next Health—a medical lab in Texas—and those same physicians were also given illegal kickbacks as compensation, the DOJ said.

Next Health went on to submit $3 million in claims to Medicare, insurance companies and patients. Many of the tests were totally unnecessary. According to the DOJ, the lab was complicit in the scheme, offering 50 percent of the net profit for eligible specimens submitted by Gallups.

Oxendine attempted to cover up the scheme by instructing Gallups to lie to federal agents during their investigation. Oxendine used part of the kickback money to pay for Gallups’ legal fees after he faced charges, the DOJ added. 

Oxendine also allegedly used part of the kickback profits to make tax-deductible charitable donations.

“Oxendine abused his position as the former Georgia Insurance Commissioner by undermining the integrity of the state’s healthcare system when he conspired with a physician to order hundreds of unnecessary and costly lab tests,” U.S. Attorney Ryan K. Buchanan said in a statement. “This case demonstrates our office’s commitment to work with our law enforcement partners to hold individuals accountable who prioritize personal greed at the expense of the public’s trust.”

Oxendine is 62 years old. After his three and a half year term behind bars, he will be subjected to three years of supervised release. He was also ordered to pay $760,175.34 in restitution and a $25,000 fine. 

Gallups is currently serving his 33 month prison sentence after being convicted in a separate criminal trial. 

The conspiracy was investigated by cooperating agents from the Federal Bureau of Investigation and the Office of Inspector General’s Defense Criminal Investigative Service.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.